May 1, 2014 Investing and Market Analysis OncoGenex Posts Wider Loss, Beats Revenues – Analyst Blog OncoGenex Pharmaceuticals, Inc. ( OGXI ) reported a loss of 59 cents per share in the first quarter of …read more
